Real‐world persistence with liraglutide 3.0 mg for weight management and the SaxendaCare® patient support program

OBJECTIVE: Weight management medications can significantly increase patients' chances of achieving a clinically meaningful weight loss if patients persist with treatment. This retrospective observational study of de‐identified medical records of 311 patients is the first real‐world study examin...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Obes Sci Pract
Egile Nagusiak: Wharton, Sean, Haase, Christiane L, Kamran, Elham, Liu, Aiden, Mancini, Johanna, Neish, Drew, Pakseresht, Arash, Power, G Sarah, Christensen, Rebecca AG
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2020
Gaiak:
Original Research Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7448157/
https://ncbi.nlm.nih.gov/pubmed/32874673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/osp4.419
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak